Biostar Pharmaceuticals, Inc.: 10-Q filed 2015-08-19
What Biostar Pharmaceuticals, Inc. reported in its quarterly report filed 2015-08-19 (fiscal Q2 2015): 40 published measures, 115 facts as tagged in accession 0001185185-15-002253.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-08-19
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001185185-15-002253 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Biostar Pharmaceuticals, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 81,950,876 | USD | |
| At 2014-12-31 | 81,247,231 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 72,343,805 | USD | |
| At 2014-12-31 | 72,335,351 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 313,320 | USD | |
| At 2014-12-31 | 1,685,154 | USD | |
| At 2014-06-30 | 9,341,104 | USD | |
| At 2013-12-31 | 80,072 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -492,427 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -652,531 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,645,494 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,952,164 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 439,558 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 1,036,577 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 30,760 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 479,792 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -188,121 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 7,153,965 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -1,666,591 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 1,085,889 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 27,617,425 | USD | |
| At 2014-12-31 | 28,269,956 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 15,476,113 | shares | 91 |
| 2015-01-01 to 2015-06-30 | 15,476,113 | shares | 181 |
| 2014-04-01 to 2014-06-30 | 14,326,113 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 13,678,875 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 15,476,113 | shares | 91 |
| 2015-01-01 to 2015-06-30 | 15,476,113 | shares | 181 |
| 2014-04-01 to 2014-06-30 | 14,326,113 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 13,681,830 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -0.03 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.04 | USD/shares | 181 |
| 2014-04-01 to 2014-06-30 | 0.11 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | 0.14 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -0.03 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.04 | USD/shares | 181 |
| 2014-04-01 to 2014-06-30 | 0.11 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | 0.14 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -169,072 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -647,943 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -466,649 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -167,408 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 8,310,684 | USD | |
| At 2014-12-31 | 8,483,113 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 0 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 199,100 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -1,073,184 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -1,963,182 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 455,348 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -307,764 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 42,663,774 | USD | |
| At 2014-12-31 | 43,633,047 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,396 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 62,851 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 0 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 9,607,071 | USD | |
| At 2014-12-31 | 8,911,880 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 12,690,199 | USD | |
| At 2014-12-31 | 13,270,330 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 28,931,939 | USD | |
| At 2014-12-31 | 26,962,078 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 7,011,863 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 11,483,111 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 8,812,190 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 16,828,390 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 517,857 | USD | |
| At 2014-12-31 | 673,989 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 5,938,679 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 9,519,929 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 9,267,538 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 16,520,626 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,026,177 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 2,044,789 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 689,488 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,384,432 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 15,476,113 | shares | |
| At 2014-12-31 | 15,476,113 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 30,303,508 | USD | |
| At 2014-12-31 | 30,303,508 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 7,052,983 | USD | |
| At 2014-12-31 | 6,391,998 | USD | |
| At 2013-12-31 | 6,600,454 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 11,615,104 | USD | |
| At 2014-12-31 | 11,476,623 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 3,304,420 | USD | |
| At 2014-12-31 | 2,993,510 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 12,690,199 | USD | |
| At 2014-12-31 | 13,270,330 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 2,978,567 | USD | |
| At 2014-12-31 | 4,471,992 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -212,507 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 8,454 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,744,443 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,517,134 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -492,427 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -652,531 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,645,494 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,952,764 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,183,795 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 1,959,550 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,690,465 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,018,770 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 2,080 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 2,080 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -4,132 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -50,832 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 411,685 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 662,708 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 723,497 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,092,520 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 2,882,616 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 9,059,901 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -161,123 | USD | 181 |
| 2014-01-01 to 2014-06-30 | -155,118 | USD | 181 |
Inspect the source
- Entity
- Biostar Pharmaceuticals, Inc. / CIK 0001418133
- Captured
- SEC response SHA-256
65bfcb22925fcd8d50013fde5b00c59d0adcec0a6e09b2504502010fb5944726
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001418133.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))